These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38607687)

  • 1. Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.
    Keshtkarjahromi M; Rebman AW; Antar AAR; Manabe YC; Gutierrez-Alamillo L; Casciola-Rosen LA; Aucott JN; Miller JB
    Clin Exp Rheumatol; 2024 Jul; 42(7):1487-1490. PubMed ID: 38607687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease.
    Maccallini P; Bonin S; Trevisan G
    Med Hypotheses; 2018 Jan; 110():1-8. PubMed ID: 29317049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.
    Tang KS; Klempner MS; Wormser GP; Marques AR; Alaedini A
    Clin Infect Dis; 2015 Dec; 61(11):1703-6. PubMed ID: 26219695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.
    Strle K; Sulka KB; Pianta A; Crowley JT; Arvikar SL; Anselmo A; Sadreyev R; Steere AC
    Clin Infect Dis; 2017 Apr; 64(7):930-938. PubMed ID: 28077518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.
    Chandra A; Wormser GP; Marques AR; Latov N; Alaedini A
    Clin Vaccine Immunol; 2011 May; 18(5):767-71. PubMed ID: 21411605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Anti-
    Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
    Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of Borrelia burgdorferi seropositivity in an area endemic for Lyme disease.
    Jochimsen E; Sikkink J; Marx JJ
    Wis Med J; 1990 Dec; 89(12):677-81. PubMed ID: 2293487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-specific symptoms in adult patients referred to a Lyme centre.
    Zomer TP; Barendregt JNM; van Kooten B; van Bemmel T; Landman GW; van Hees BC; Vermeeren YM
    Clin Microbiol Infect; 2019 Jan; 25(1):67-70. PubMed ID: 30287411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors.
    Brummitt SI; Kjemtrup AM; Harvey DJ; Petersen JM; Sexton C; Replogle A; Packham AE; Bloch EM; Barbour AG; Krause PJ; Green V; Smith WA
    PLoS One; 2020; 15(12):e0243950. PubMed ID: 33370341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
    Dattwyler RJ; Volkman DJ; Luft BJ; Halperin JJ; Thomas J; Golightly MG
    N Engl J Med; 1988 Dec; 319(22):1441-6. PubMed ID: 3054554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Transcriptome Analysis Identifies a Diagnostic Signature for Early Disseminated Lyme Disease and Its Resolution.
    Petzke MM; Volyanskyy K; Mao Y; Arevalo B; Zohn R; Quituisaca J; Wormser GP; Dimitrova N; Schwartz I
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
    Richter AG; Shields AM; Karim A; Birch D; Faustini SE; Steadman L; Ward K; Plant T; Reynolds G; Veenith T; Cunningham AF; Drayson MT; Wraith DC
    Clin Exp Immunol; 2021 Aug; 205(2):99-105. PubMed ID: 34082475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.
    Uhde M; Ajamian M; Li X; Wormser GP; Marques A; Alaedini A
    Clin Infect Dis; 2016 Dec; 63(11):1399-1404. PubMed ID: 27585799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lyme disease in Tunisia, results of a clinical and serological study (1992-1996)].
    Aoun K; Kechrid A; Lagha N; Zarrouk A; Bouzouaia N
    Sante; 1998; 8(2):98-100. PubMed ID: 9642728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme disease: an infectious and postinfectious syndrome.
    Asch ES; Bujak DI; Weiss M; Peterson MG; Weinstein A
    J Rheumatol; 1994 Mar; 21(3):454-61. PubMed ID: 8006888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.